Who to call at PHC株式会社 バイオメディカ事業部, and when
Fundz watches for the moments PHC株式会社 バイオメディカ事業部 starts buying, and tells you who to reach.
- An alert the day PHC株式会社 バイオメディカ事業部 raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PHC株式会社 バイオメディカ事業部, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PHC株式会社 バイオメディカ事業部. With Fundz connected, it knows.
LaunchPHC Corporation Launches LiCellMo, a Live Cell Metabolic Analyzer, to Enhance Research in Cell and Gene Therapy.
JapanManufacturingBiotechnologyHealth CareMedicalMedical DeviceImage RecognitionProduct Description
PHC Corporation has launched LiCellMo, a live cell metabolic analyzer that provides continuous measurement of cellular metabolic pathways, enabling researchers to monitor changes in cell conditions in real-time. The product aims to enhance the reproducibility and quality of cell cultures in cell and gene therapy research.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PHC株式会社 バイオメディカ事業部 ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Product Launch Insights
What this usually meansPHC株式会社 バイオメディカ事業部 shipped something new. Fundz reads product launches, trademark filings and hiring together.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.